P3 HEALTH PARTNERS INC (PIII)
US7444131053 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 637.4M 31.29% | 1.05B 64.65% | 1.266B 20.66% | 1.538B 21.45% | 1.52B -1.17% | 1.703B 12.04% | |
| EBITDA YoY % growth | -179.17M -422.36% | -158.61M 11.48% | -81.255M 48.77% | -130.52M -60.63% | -32.008M 75.48% | 31.722M 199.11% | |
| EBIT YoY % growth | -187.9M -435.33% | -245.9M -30.87% | -167.93M 31.71% | -240.146M -43.00% | -147.792M 38.46% | -110.773M 25.05% | |
| Operating Margin | -29.48% | -23.43% | -13.26% | -15.61% | -9.72% | -6.50% | |
| EPS YoY % growth | N/A | -2.99 -236.94% | -0.65 78.26% | -0.66 -1.61% | -0.40 39.38% | -0.43 -7.01% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 49.00% | -0.14 15.00% | -0.08 5.56% | -0.13 54.28% | -0.12 -6.06% |
| Revenue Q2Q % growth | 385.62M 11.17% | 399.3M 2.78% | 380.56M 0.37% | 367.17M 1.39% | 383.11M -0.65% |
| EBITDA Q2Q % growth | -21.976M -198.04% | -13.553M 39.20% | -5.786M -148.63% | -12.569M 70.13% | -13.635M 37.96% |
| EBIT Q2Q % growth | -54.317M 15.47% | -37.273M 14.96% | -28.115M 10.27% | -39.759M 62.84% | -32.23M 40.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.29 -141.67% | -0.04 | -0.25 | -658.17% |
| Q2 2024 Q2Q % growth | -0.09 | -0.05 | -0.04 | -76.47% |
| Q1 2024 Q2Q % growth | -0.16 27.27% | -0.11 | -0.05 | -47.05% |
| Q4 2023 Q2Q % growth | -0.22 90.27% | -0.11 | -0.11 | -96.08% |
| Q3 2023 Q2Q % growth | -0.12 55.56% | -0.22 | 0.10 | 46.52% |
| Q2 2023 Q2Q % growth | -0.09 57.14% | -0.13 | 0.04 | 32.13% |
| Q1 2023 Q2Q % growth | -0.22 12.00% | -0.69 | 0.47 | 68.05% |
| Q4 2022 Q2Q % growth | -2.26 -841.67% | -0.93 | -1.33 | -143.48% |
| Q3 2022 Q2Q % growth | -0.27 | -0.47 | 0.20 | 42.87% |
| Q2 2022 Q2Q % growth | -0.21 | -0.16 | -0.05 | -28.68% |
| Q1 2022 Q2Q % growth | -0.25 | -0.13 | -0.12 | -98.73% |
| Q4 2021 Q2Q % growth | -0.24 | -0.25 | 0.01 | 3.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 362.124M 25.58% | 371.74M | -9.616M | -2.59% |
| Q2 2024 Q2Q % growth | 379.157M 15.22% | 391.14M | -11.983M | -3.06% |
| Q1 2024 Q2Q % growth | 388.488M 28.61% | 359.51M | 28.978M | 8.06% |
| Q4 2023 Q2Q % growth | 346.861M 34.34% | 309.03M | 37.831M | 12.24% |
| Q3 2023 Q2Q % growth | 288.351M 16.13% | 299.28M | -10.929M | -3.65% |
| Q2 2023 Q2Q % growth | 329.086M 22.11% | 310.01M | 19.076M | 6.15% |
| Q1 2023 Q2Q % growth | 302.077M 10.45% | 288.56M | 13.517M | 4.68% |
| Q4 2022 Q2Q % growth | 258.2M 45.14% | 258.01M | 190K | 0.07% |
| Q3 2022 Q2Q % growth | 248.3M 58.66% | 263.21M | -14.91M | -5.66% |
| Q2 2022 Q2Q % growth | 269.5M -11.05% | 237.46M | 32.04M | 13.49% |
| Q1 2022 Q2Q % growth | 273.5M | 204.07M | 69.43M | 34.02% |
| Q4 2021 Q2Q % growth | 177.9M 42.43% | 182.42M | -4.52M | -2.48% |
| Q3 2021 Q2Q % growth | 156.5M 21.51% | % | ||
| Q2 2021 Q2Q % growth | 302.983M 30.70% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -312.45% | 0% | -125.22% |
| Revenue | 0% | -3.4% | 0% | -1.09% |